- Décision 249
This decision sets the list of so-called "stringent" pharmaceutical authorities and of the authorities recognised by the Agency. It serves as a reference for regulatory reliance procedures: a product already assessed by one of these authorities benefits from streamlined review arrangements.
Record updated on